Alexis Peyroles
Chief Executive Officer chez Ose Immunotherapeutics, Inc.
Fortune : 5 M $ au 31/03/2024
Profil
Alexis Peyroles currently works at Ose Immunotherapeutics, Inc., as Chief Executive Officer and Aperana Consulting SAS, as Chairman.
Mr. Peyroles also formerly worked at OSE Immunotherapeutics SA, as Chief Executive Officer & Director from 2018 to 2022, Guerbet Imagem do Brasil Ltda., as Chief Executive Officer, Guerbet SA, as Manager-Financial Control, Sanofi-Aventis Japan, as Head-Financial Control-Baltic States, Sanofi-Aventis France SA, as Head-Eastern Europe Business Development, and Orphan Synergy Europe-Pharma SA, as CFO & Head-Business Development.
Mr. Peyroles received his undergraduate degree from École des Hautes Études Commerciales du Nord and Masters Business Admin degree from Imperial College Business School.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
31/12/2022 | 929 862 ( 4,27% ) | 5 M $ | 31/03/2024 |
Postes actifs de Alexis Peyroles
Sociétés | Poste | Début |
---|---|---|
Aperana Consulting SAS | Chairman | - |
Ose Immunotherapeutics, Inc. | Chief Executive Officer | - |
Anciens postes connus de Alexis Peyroles
Sociétés | Poste | Fin |
---|---|---|
OSE IMMUNOTHERAPEUTICS | Chief Executive Officer | 16/01/2022 |
Guerbet Imagem do Brasil Ltda. | Chief Executive Officer | - |
Sanofi-Aventis Japan | Comptroller/Controller/Auditor | - |
GUERBET | Comptroller/Controller/Auditor | - |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Corporate Officer/Principal | - |
Formation de Alexis Peyroles
École des Hautes Études Commerciales du Nord | Undergraduate Degree |
Imperial College Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
GUERBET | Health Technology |
OSE IMMUNOTHERAPEUTICS | Health Technology |
Entreprise privées | 6 |
---|---|
Sanofi-Aventis Japan | |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
Aperana Consulting SAS | |
Ose Immunotherapeutics, Inc. | |
Guerbet Imagem do Brasil Ltda. |